Measurement of Protein X by LC-MRM/MS Using the AQUA Approach in Dissected FFPE Breast and Gastric Tumor Tissue

Posters Nov 4, 2018

Oncology

Mass Spectrometry

November 4, 2018

Vanessa Diniz Atayde¹, Anne Jang¹, Valerie Hindie¹, Michael Schirm¹, Rudolf Guilbaud¹, Guido Steiner², Lorella Di Donato¹ and Axel Ducret². ¹ Caprion Biosciences Inc., ² Roche Pharma Research & Early Development

Measurement of Protein X by LC-MRM/MS Using the AQUA Approach in Dissected FFPE Breast and Gastric Tumor Tissue, AAPS 2018

Posters

Apr 14, 2026

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS

Posters

Mar 3, 2026

Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity

Posters

Mar 3, 2026

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.

Measurement of Protein X by LC-MRM/MS Using the AQUA Approach in Dissected FFPE Breast and Gastric Tumor Tissue

Featured Resources

Understanding Protein Normalization: A Case Study in PBMC Fit-for-Purpose Validation by MS

Challenging Hybrid Affinity Approach: Streamlined Total Antibody Quantitation with Uncompromised Sensitivity

Patient-Centric Measurement of M-Protein Using High-Resolution Intact Mass Spectrometry

One global CRO for your whole therapeutic development journey